Covered recipient · General Payments record
CARL G CHAKMAKJIAN
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2024
$284,069.04
- Reported across 314 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19,693.00 | 4 |
| Travel and Lodging | $3,297.45 | 6 |
| Food and Beverage | $948.61 | 35 |
| Consulting Fee | $900.00 | 2 |
| Education | $11.88 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $24,187.20 | 16 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $73.42 | 3 |
| EISAI INC. | $58.78 | 2 |
| Daiichi Sankyo Inc. | $58.55 | 2 |
| Celgene Corporation | $53.03 | 3 |
| Merck Sharp & Dohme Corporation | $52.25 | 2 |
| Regeneron Healthcare Solutions, Inc. | $49.90 | 2 |
| Acerta Pharma LLC | $45.68 | 2 |
| PFIZER INC. | $36.02 | 3 |
| ADC Therapeutics America, Inc. | $27.93 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $24.82 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $24.14 | 1 |
| Incyte Corporation | $22.09 | 1 |
| Genmab U.S., Inc. | $21.71 | 1 |
| Gilead Sciences, Inc. | $20.42 | 1 |
| GlaxoSmithKline, LLC. | $19.19 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $17.79 | 1 |
| SOBI, INC | $16.30 | 1 |
| Tempus AI, Inc | $15.00 | 1 |
| Janssen Biotech, Inc. | $13.46 | 1 |
| GENZYME CORPORATION | $13.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (48)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.